Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 5 trials in this atlas.

  • Organization
  • In this atlas

Overview

Technical summary

Sponsor class industry. No ROR record matches the name exactly.

Trials at a glance

These figures count only the registry trials in this atlas that name Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA as a sponsor: 5 trials, 5 as lead sponsor and 0 as collaborator.

Phase and status

Trials by phase and registry status
PhaseCompletedTerminatedAll statuses
Phase 2202
Phase 3213
All phases415

Start year

Trials started per year
Start yearTrials
20221
20213
20181

Main countries

  • France 5 trials
  • Germany 5 trials
  • Israel 5 trials
  • Spain 5 trials
  • United Kingdom 5 trials

Roles

  • Company
  • Sponsor

Sector

Industry

The registry's words

Labels as the registry gives them, not rewritten.

Sponsor name
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA
Sponsor class
INDUSTRY

Record details

Record id
cardio:org-acceleron-pharma-inc-a-wholly-owned-subsidiary-of-merck-co-341e98
Content hash
fe4673c0e94ae6cd53cab67aefc77d6c9303a3837b9e8cf63422d681a5ad3ceb